$TSNDF
TerrAscend Corp. Stock $tsndf

$tsndf Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024031450 Filed on March 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q2
Revenue	$80.63M	$86.57M	$72.12M
YoY Change	16.19%	30.49%	11.3%
Cost Of Revenue	$41.90M	$44.80M	$35.90M
YoY Change	18.04%	63.9%	-14.14%
Gross Profit	$38.73M	$41.77M	$36.23M
YoY Change	14.25%	7.07%	57.55%
Gross Profit Margin	48.03%	48.25%	50.23%
Selling, General & Admin	$28.01M	$27.68M	$30.48M
YoY Change	1.0%	-6.69%	-10.31%
% of Gross Profit	72.31%	66.28%	84.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.037M	$5.203M	$3.395M
YoY Change	-6.75%	53.8%	12.16%
% of Gross Profit	7.84%	12.46%	9.37%
Operating Expenses	$32.66M	$30.18M	$32.73M
YoY Change	8.53%	-1.57%	-11.54%
Operating Profit	$6.070M	$11.59M	$3.498M
YoY Change	59.49%	38.81%	-124.98%
Interest Expense	-$10.14M	-$6.539M	-$9.310M
YoY Change	25.09%	-765.89%	-124.62%
% of Operating Profit	-167.05%	-56.44%	-266.15%
Other Income/Expense, Net	$283.0K	$365.0K	-$206.0K
YoY Change	1079.17%	-85.32%	-31.56%
Pretax Income	-$5.180M	-$51.02M	-$6.407M
YoY Change	-20.48%	-280.61%	-133.99%
Income Tax	$9.671M	-$9.202M	$6.448M
% Of Pretax Income
Net Earnings	-$14.85M	-$44.14M	-$13.48M
YoY Change	-34.78%	225.6%	-201.96%
Net Earnings / Revenue	-18.42%	-50.99%	-18.68%
Basic Earnings Per Share	-$0.06		-$0.05
Diluted Earnings Per Share	-$0.06	-$0.15	-$0.05
COMMON SHARES
Basic Shares Outstanding	291.2M	287.3M	274.7M
Diluted Shares Outstanding	290.6M		275.2M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.63M	$24.15M	$30.80M
YoY Change	-29.54%	-18.82%	-41.33%
Cash & Equivalents	$22.66M	$22.24M	$28.92M
Short-Term Investments	$1.965M	$1.913M	$1.900M
Other Short-Term Assets	$6.814M	$8.004M	$12.30M
YoY Change	-64.18%	-65.89%	48.91%
Inventory	$49.20M	$51.68M	$54.02M
Prepaid Expenses
Receivables	$17.01M	$19.05M	$9.478M
Other Receivables	$1.402M	$1.562M	$1.100M
Total Short-Term Assets	$97.66M	$102.9M	$106.6M
YoY Change	-14.18%	-15.66%	-22.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$194.3M	$196.2M	$209.0M
YoY Change	-9.24%	-9.08%	-12.48%
Goodwill	$106.9M	$106.9M	$99.95M
YoY Change	11.72%	18.38%	-58.46%
Intangibles	$214.1M	$215.9M	$269.6M
YoY Change	-12.18%	-9.95%	-23.33%
Long-Term Investments
YoY Change
Other Assets	$867.0K	$854.0K	$848.0K
YoY Change	-75.88%	-75.33%	-83.03%
Total Long-Term Assets	$557.9M	$563.6M	$615.1M
YoY Change	-5.09%	-2.75%	-29.4%
TOTAL ASSETS
Total Short-Term Assets	$97.66M	$102.9M	$106.6M
Total Long-Term Assets	$557.9M	$563.6M	$615.1M
Total Assets	$655.5M	$666.5M	$721.7M
YoY Change	-6.56%	-5.0%	-28.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$49.67M	$49.90M	$50.80M
YoY Change	-2.19%	12.67%	-11.71%
Accrued Expenses	$1.816M	$1.244M	$1.900M
YoY Change	-21.52%	138.77%	394.79%
Deferred Revenue
YoY Change
Short-Term Debt	$9.123M	$11.85M	$0.00
YoY Change
Long-Term Debt Due	$124.5M	$125.9M	$24.20M
YoY Change	139.82%	150.81%	-59.83%
Total Short-Term Liabilities	$199.1M	$207.0M	$133.5M
YoY Change	27.58%	50.1%	-4.92%
LONG-TERM LIABILITIES
Long-Term Debt	$66.47M	$69.31M	$189.0M
YoY Change	-56.49%	-54.57%	1.85%
Other Long-Term Liabilities	$140.9M	$132.3M	$16.37M
YoY Change	789.6%	737.75%	30.92%
Total Long-Term Liabilities	$224.3M	$218.8M	$292.7M
YoY Change	-8.89%	-9.79%	-9.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$199.1M	$207.0M	$133.5M
Total Long-Term Liabilities	$224.3M	$218.8M	$292.7M
Total Liabilities	$423.4M	$425.8M	$426.1M
YoY Change	5.26%	11.92%	-8.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$717.4M	-$704.2M	-$653.6M
YoY Change	11.83%	13.89%	107.41%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)		$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$230.6M	$242.5M	$293.6M
YoY Change
Total Liabilities & Shareholders Equity	$655.5M	$666.5M	$721.7M
YoY Change	-6.56%	-5.0%	-28.44%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q2
OPERATING ACTIVITIES
Net Income	-$14.85M	-$44.14M	-$13.48M
YoY Change	-34.78%	225.6%	-201.96%
Depreciation, Depletion And Amortization	$3.037M	$5.203M	$3.395M
YoY Change	-6.75%	53.8%	12.16%
Cash From Operating Activities	$13.25M	$9.419M	$690.0K
YoY Change	57.11%	28.89%	-104.28%
INVESTING ACTIVITIES
Capital Expenditures	$2.796M	$2.942M	$2.260M
YoY Change	11.97%	-81.48%	-123.71%
Acquisitions
YoY Change
Other Investing Activities	-$500.0K	$15.00K	$8.960M
YoY Change	-94.49%	-98.31%	-302.67%
Cash From Investing Activities	-$3.423M	-$2.927M	$6.700M
YoY Change	-70.44%	-80.48%	-148.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$12.22M		$28.24M
YoY Change	914.53%
Cash From Financing Activities	-9.599M	-9.517M	-4.980M
YoY Change	-202.14%	423.49%	-39.91%
NET CHANGE
Cash From Operating Activities	13.25M	9.419M	690.0K
Cash From Investing Activities	-3.423M	-2.927M	6.700M
Cash From Financing Activities	-9.599M	-9.517M	-4.980M
Net Change In Cash	229.0K	-3.025M	2.410M
YoY Change	-96.34%	-68.18%	-106.28%
FREE CASH FLOW
Cash From Operating Activities	$13.25M	$9.419M	$690.0K
Capital Expenditures	$2.796M	$2.942M	$2.260M
Free Cash Flow	$10.46M	$6.477M	-$1.570M
YoY Change	76.1%	-175.52%	-76.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001778129
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2023	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56363
CY2023	dei	Entity Registrant Name EntityRegistrantName	TERRASCEND CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A6
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	77 City Centre Drive
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 501 - East Tower
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Mississauga
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	ON
CY2023	dei	Entity Address Country EntityAddressCountry	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	L5B 1M5
CY2023	dei	City Area Code CityAreaCode	717
CY2023	dei	Local Phone Number LocalPhoneNumber	610-4165
CY2023	dei	Security12g Title Security12gTitle	Common Shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	351317574
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	291215585
CY2023	dei	Auditor Firm AuditorFirmId	1930
CY2023	dei	Auditor Name AuditorName	MNP LLP
CY2023	dei	Auditor Location AuditorLocation	Toronto, Canada
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22241000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26158000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3106000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	605000
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	61633000
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	145852000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45384000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31545000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	407000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19048000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22443000
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	1913000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	3595000
CY2023Q4	us-gaap	Inventory Net InventoryNet	51683000
CY2022Q4	us-gaap	Inventory Net InventoryNet	46335000
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	17349000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4898000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5508000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	102889000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	121993000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	196215000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	215812000
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	337000
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	837000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43440000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29451000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	215854000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239704000
CY2023Q4	us-gaap	Goodwill Goodwill	106929000
CY2022Q4	us-gaap	Goodwill Goodwill	90328000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	854000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3462000
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	563629000
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	579594000
CY2023Q4	us-gaap	Assets Assets	666518000
CY2022Q4	us-gaap	Assets Assets	701587000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	49897000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	44286000
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4154000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2935000
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	137737000
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	48335000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	6446000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5184000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1244000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1857000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2030000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	521000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4775000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	23077000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	717000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2599000
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	9111000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	207000000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	137905000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6713000
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5162000
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	711000
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	7266000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	17175000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	30700000
CY2022Q4	tsndf	Financing Obligations Noncurrent FinancingObligationsNoncurrent	11198000
CY2023Q4	tsndf	Liability On Uncertain Tax Position And Other Long Term Liabilities LiabilityOnUncertainTaxPositionAndOtherLongTermLiabilities	81751000
CY2022Q4	tsndf	Liability On Uncertain Tax Position And Other Long Term Liabilities LiabilityOnUncertainTaxPositionAndOtherLongTermLiabilities	15792000
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	218778000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	242511000
CY2023Q4	us-gaap	Liabilities Liabilities	425778000
CY2022Q4	us-gaap	Liabilities Liabilities	380416000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	288327497
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	259624531
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	944859000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	934972000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1799000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2085000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-704162000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-618260000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1756000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2374000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240740000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321171000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	666518000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	701587000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	317328000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247829000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	194210000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	157630000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	146325000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	81708000
CY2023	us-gaap	Gross Profit GrossProfit	159698000
CY2022	us-gaap	Gross Profit GrossProfit	101504000
CY2021	us-gaap	Gross Profit GrossProfit	112502000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	115189000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	115588000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	75107000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9433000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9658000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5533000
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	51303000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	140727000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3633000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4690000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	170357000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5007000
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	2079000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1089000
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	312000
CY2023	us-gaap	Operating Expenses OperatingExpenses	182694000
CY2022	us-gaap	Operating Expenses OperatingExpenses	437419000
CY2021	us-gaap	Operating Expenses OperatingExpenses	89592000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-22996000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-335915000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	22910000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-645000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1061000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3584000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4153000
CY2023	tsndf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	322000
CY2022	tsndf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	58523000
CY2021	tsndf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	57904000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1914000
CY2023	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	37041000
CY2022	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	35893000
CY2021	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	27849000
CY2023	tsndf	Transaction And Restructuring Costs TransactionAndRestructuringCosts	344000
CY2022	tsndf	Transaction And Restructuring Costs TransactionAndRestructuringCosts	1445000
CY2021	tsndf	Transaction And Restructuring Costs TransactionAndRestructuringCosts	3111000
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	1217000
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-3278000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	53000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-712000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4654000
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2603000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	43000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	6192000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58833000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-310185000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44530000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23453000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10783000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28877000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-82286000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-299402000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	15653000
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-4444000
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-25949000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13316000
CY2021	tsndf	Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnits	50000000
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-9518000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-86730000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-325351000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6135000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-286000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-738000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	6485000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-87016000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-326089000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	12620000
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-91101000
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-303959000
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12629000
CY2023	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	8815000
CY2022	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	4557000
CY2021	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	3024000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-95831000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-330646000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9596000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	8815000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4557000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3024000
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.33
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.24
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.07
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.02
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.11
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.05
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.35
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	279285588
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	244351028
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	181056654
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.33
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.24
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.06
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.02
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.11
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.05
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	279285588
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	244351028
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	208708664
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	34427000
CY2021	tsndf	Stock Issued During Period Value Liability Settlement StockIssuedDuringPeriodValueLiabilitySettlement	80000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14941000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	5656000
CY2021	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	48878000
CY2021	tsndf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	-53000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6135000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6485000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	228954000
CY2022	tsndf	Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnits	25927000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	331983000
CY2022	tsndf	Stock Issued During Period Value Liability Settlement StockIssuedDuringPeriodValueLiabilitySettlement	264000
CY2022	tsndf	Stock Issued During Period Value Debt Settlement Agreement StockIssuedDuringPeriodValueDebtSettlementAgreement	55520000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12162000
CY2022	tsndf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	-7550000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-325351000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-738000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321171000
CY2023	tsndf	Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnits	98000
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	8601000
CY2023	tsndf	Stock Options And Warrants Issued During Period Value Legal Settlement StockOptionsAndWarrantsIssuedDuringPeriodValueLegalSettlement	794000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1000000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7707000
CY2023	tsndf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	-11622000
CY2023	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	7500000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-86730000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-286000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240740000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-82286000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-299402000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	15653000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	985000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	9082000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	4941000
CY2023	tsndf	Accretion Expenses Net AccretionExpensesNet	-10674000
CY2022	tsndf	Accretion Expenses Net AccretionExpensesNet	-9740000
CY2021	tsndf	Accretion Expenses Net AccretionExpensesNet	-4273000
CY2023	tsndf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	20382000
CY2022	tsndf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	22624000
CY2021	tsndf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	12789000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2319000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1980000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1074000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	7707000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	12162000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	14941000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-18615000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-35299000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1245000
CY2023	tsndf	Gain Loss On Warrants And Derivative GainLossOnWarrantsAndDerivative	322000
CY2022	tsndf	Gain Loss On Warrants And Derivative GainLossOnWarrantsAndDerivative	58523000
CY2021	tsndf	Gain Loss On Warrants And Derivative GainLossOnWarrantsAndDerivative	57904000
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1914000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-645000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1061000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3584000
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	55993000
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	311084000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	8640000
CY2023	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	2079000
CY2022	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	1089000
CY2021	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	312000
CY2023	tsndf	Gain Loss On Derecognition Of Right Of Use Assets And Lease Termination GainLossOnDerecognitionOfRightOfUseAssetsAndLeaseTermination	-1217000
CY2022	tsndf	Gain Loss On Derecognition Of Right Of Use Assets And Lease Termination GainLossOnDerecognitionOfRightOfUseAssetsAndLeaseTermination	1163000
CY2021	tsndf	Gain Loss On Derecognition Of Right Of Use Assets And Lease Termination GainLossOnDerecognitionOfRightOfUseAssetsAndLeaseTermination	3278000
CY2022	tsndf	Release Of Indemnification Asset ReleaseOfIndemnificationAsset	3973000
CY2021	tsndf	Release Of Indemnification Asset ReleaseOfIndemnificationAsset	4504000
CY2021	tsndf	Forgiveness Of Loan Principal And Interest ForgivenessOfLoanPrincipalAndInterest	1414000
CY2022	tsndf	Bad Debt Expense BadDebtExpense	9941000
CY2022	tsndf	Employee Retention Credits Recorded In Other Income EmployeeRetentionCreditsRecordedInOtherIncome	9440000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4153000
CY2022	tsndf	Debt Modification Fees Expensed DebtModificationFeesExpensed	-2507000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	53000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-712000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4654000
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2603000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	43000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	6192000
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	9259000
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2862000
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	3209000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5185000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-676000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18508000
CY2023	tsndf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	-1198000
CY2022	tsndf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	-856000
CY2021	tsndf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	1649000
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-500000
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-3666000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-797000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-711000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	726000
CY2023	tsndf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	644000
CY2022	tsndf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	-12103000
CY2021	tsndf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	2820000
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1861000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1314000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-663000
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2070000
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-13846000
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	6440000
CY2023	tsndf	Increase Decrease In Uncertain Tax Position Liabilities IncreaseDecreaseInUncertainTaxPositionLiabilities	66404000
CY2022	tsndf	Increase Decrease In Uncertain Tax Position Liabilities IncreaseDecreaseInUncertainTaxPositionLiabilities	3905000
CY2021	tsndf	Increase Decrease In Uncertain Tax Position Liabilities IncreaseDecreaseInUncertainTaxPositionLiabilities	-2690000
CY2022	tsndf	Increase Decrease In Contingent Consideration Payable IncreaseDecreaseInContingentConsiderationPayable	-410000
CY2021	tsndf	Increase Decrease In Contingent Consideration Payable IncreaseDecreaseInContingentConsiderationPayable	-11394000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-18946000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	14598000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-6938000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1219000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	428000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	467000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	31131000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-21835000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-24162000
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-3660000
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-4288000
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-7653000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27471000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26123000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31815000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7762000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39631000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39835000
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1666000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2261000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	376000
CY2022	us-gaap	Proceeds From Collection Of Lease Receivables ProceedsFromCollectionOfLeaseReceivables	515000
CY2021	us-gaap	Proceeds From Collection Of Lease Receivables ProceedsFromCollectionOfLeaseReceivables	677000
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	469000
CY2021	us-gaap	Payments To Acquire Limited Partnership Interests PaymentsToAcquireLimitedPartnershipInterests	50000000
CY2022	tsndf	Deposits For Business Acquisition DepositsForBusinessAcquisition	1065000
CY2023	tsndf	Success Fees Related To Atc And Other Investment SuccessFeesRelatedToATCAndOtherInvestment	3012000
CY2023	tsndf	Payment For Land Contracts PaymentForLandContracts	1275000
CY2022	tsndf	Payment For Land Contracts PaymentForLandContracts	1271000
CY2023	tsndf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	16789000
CY2022	tsndf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	-16227000
CY2021	tsndf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	42736000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-30504000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-27486000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-131801000
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	14285000
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-93000
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-620000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16219000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27579000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-132421000
CY2023	tsndf	Transfer Of Employee Retention Credit TransferOfEmployeeRetentionCredit	12677000
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	23869000
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	43419000
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	766000
CY2023	tsndf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	98000
CY2022	tsndf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	24342000
CY2021	tsndf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	30785000
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	50154000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	42221000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4500000
CY2023	tsndf	Payment Loan Amendment Fee And Prepayment Premium PaymentLoanAmendmentFeeAndPrepaymentPremium	1178000
CY2022	tsndf	Payment Loan Amendment Fee And Prepayment Premium PaymentLoanAmendmentFeeAndPrepaymentPremium	4977000
CY2023	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0
CY2022	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	1539000
CY2023	tsndf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	11621000
CY2022	tsndf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	7550000
CY2021	tsndf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	53000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	6630000
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	18274000
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	20822000
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	173477000
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1474000
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1125000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-6961000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3719000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	182201000
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-5539000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12500000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3719000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	182201000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1248000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-49983000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	17965000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-168000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2896000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2451000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26763000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79642000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	59226000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25347000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26763000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79642000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3280000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9917000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	37060000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	23037000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	26840000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	21171000
CY2023	tsndf	Payments For Lease Termination Fee PaymentsForLeaseTerminationFee	379000
CY2022	tsndf	Payments For Lease Termination Fee PaymentsForLeaseTerminationFee	3300000
CY2023	tsndf	Business Combination Consideration Transferred Equity Issued And Liabilities Incurred BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred	8601000
CY2022	tsndf	Business Combination Consideration Transferred Equity Issued And Liabilities Incurred BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred	338739000
CY2021	tsndf	Business Combination Consideration Transferred Equity Issued And Liabilities Incurred BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred	34427000
CY2022	tsndf	Stock Issued During Period Value Canopy Usa Arrangement StockIssuedDuringPeriodValueCanopyUsaArrangement	55520000
CY2023	tsndf	Warrant Issued As Consideration For Services WarrantIssuedAsConsiderationForServices	1000000
CY2023	tsndf	Noncash Or Part Noncash Acquisition Promissory Notes Issued NoncashOrPartNoncashAcquisitionPromissoryNotesIssued	11689000
CY2022	tsndf	Noncash Or Part Noncash Acquisition Promissory Notes Issued NoncashOrPartNoncashAcquisitionPromissoryNotesIssued	10000000
CY2021	tsndf	Noncash Or Part Noncash Acquisition Promissory Notes Issued NoncashOrPartNoncashAcquisitionPromissoryNotesIssued	8839000
CY2023	tsndf	Stock Issued During Period Value For Legal And Liability Settlement StockIssuedDuringPeriodValueForLegalAndLiabilitySettlement	794000
CY2022	tsndf	Stock Issued During Period Value For Legal And Liability Settlement StockIssuedDuringPeriodValueForLegalAndLiabilitySettlement	264000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1494000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2187000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	450000
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<div style="display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">1.</span><div id="notes_fs" style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nature of </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">operations</span></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Corp. (the "Issuer") was incorporated under the Business Corporations Act (Ontario) on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 7, 2017</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Issuer, through its subsidiaries, TerrAscend Growth Corp. (“TerrAscend”) and its subsidiaries (collectively, the Company”), is a leading North American cannabis company. TerrAscend has vertically integrated licensed operations in Pennsylvania, New Jersey, Michigan, Maryland and California. In addition, the Company has retail operations in Ontario, Canada with a majority-owned dispensary in Toronto, Ontario, Canada. In the United States, TerrAscend’s cultivation and manufacturing provide product selection to both the medical and legal adult-use markets. Notwithstanding the fact that various states in the United States have implemented medical marijuana laws or have otherwise legalized the use of cannabis, the use of cannabis remains illegal under U.S. federal law for any purpose, by way of the Controlled Substances Act of 1970 (the "Controlled Substances Act").</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company operates under one operating segment, which is the cultivation, production and sale of cannabis products.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company owns a portfolio of operating businesses, including:</span></p><div style="display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend New Jersey (“TerrAscend NJ”), a majority owned operation with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> dispensaries, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_31aac483-4bc7-4295-a9c5-5000fdf6ac68;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cultivation/processing facility;</span></div></div><div style="display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Maryland (“TerrAscend MD”), a wholly-owned operation with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">four</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> dispensaries, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_53ad9f7b-eab5-4379-a736-489b7e0846b1;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cultivation/processing facility;</span></div></div><div style="display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Pennsylvania (“TerrAscend PA”), a wholly-owned operation with six</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> dispensaries, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8f16e614-a0e8-4488-a134-2d13976761c9;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cultivation/processing facility;</span></div></div><div style="display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Michigan (“TerrAscend MI”), a wholly-owned operation with nineteen dispensaries, and three cultivation and processing facilities;</span></div></div><div style="display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend California (“TerrAscend CA”), a wholly-owned operation with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">five</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> dispensaries, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_169c722c-6497-474f-8d32-438282a5ace6;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cultivation facility; and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">; </span></div></div><div style="display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Canada Inc. (“TerrAscend Canada”) is a cannabis retailer in Ontario, Canada with a majority-owned dispensary in Toronto, Ontario, Canada ("Cookies Canada"). </span></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The common shares in the capital of the Company ("Common Shares") commenced trading on the Canadian Securities Exchange ("CSE") on May 3, 2017 under the ticker symbol "TER" and continued trading on the CSE until the listing of the Common Shares on the Toronto Stock Exchange (the "TSX"). Effective July 4, 2023, the Common Shares commenced trading on the TSX under the ticker symbol "TSND". The Common Shares commenced trading on OTCQX on October 22, 2018 under the ticker symbol "TRSSF", which was subsequently changed to "TSNDF", effective July 6, 2023. The Company’s registered office is located at 77 City Centre Drive, Suite 501, Mississauga, Ontario, L5B 1M5, Canada.</span></p>
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2017-03-07
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-704162000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22241000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-82286000
CY2023Q4	tsndf	Number Of Lessee Finance Lease NumberOfLesseeFinanceLease	2
CY2022Q4	tsndf	Number Of Lessee Finance Lease NumberOfLesseeFinanceLease	3
CY2023	tsndf	Lessee Finance Lease Option To Extend And Terminate LesseeFinanceLeaseOptionToExtendAndTerminate	Certain leases include one or more options to renew or terminate the lease at the Company’s discretion. The Company regularly evaluates lease renewal and termination options and, when they are reasonably certain of the exercise of the option to renew or terminate a lease, incorporates the renewal or termination term for accounting purpose.
CY2023	us-gaap	Lessee Finance Lease Existence Of Option To Extend LesseeFinanceLeaseExistenceOfOptionToExtend	true
CY2023	us-gaap	Lessee Finance Lease Existence Of Option To Terminate LesseeFinanceLeaseExistenceOfOptionToTerminate	true
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	6
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	0.001
CY2023	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(w) Embedded derivative liabilities</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company evaluates its financial instruments to determine if those instruments or any embedded components of those instruments qualify as derivatives that need to be separately accounted for in accordance with ASC 815, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives and Hedging</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Embedded derivatives satisfying certain criteria are recorded at fair value at issuance and marked-to-market at each balance sheet date with the change in the fair value recorded as income or expense. In addition, upon the occurrence of an event that requires the derivative liability to be reclassified to equity, the derivative liability is revalued to fair value at that date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27652010
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(z) Use of significant estimates and judgments</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the Company’s Consolidated Financial Statements requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Management has applied significant estimates and judgments related to the following:</span></p><div style="margin-left:4.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.752626672113803%;display:inline-flex;justify-content:flex-start;">i)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inventory</span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The determination of net realizable value requires significant judgment, including consideration of factors such as shrinkage, the aging of and future demand for inventory, expected future selling price the Company expects to realize by selling the inventory, and the contractual arrangements with customers. Reserves for excess and obsolete inventory are based upon quantities on hand, projected volumes from demand forecasts and net realizable value.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The future realization of these inventories may be affected by market-driven changes that may reduce future selling prices. A change to these assumptions could impact the Company’s inventory valuation and gross profit.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The impact of inventory reserves is reflected in cost of sales.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.752626672113803%;display:inline-flex;justify-content:flex-start;">ii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue recognition</span></div></div><p style="margin-left:9.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time to time, the Company partakes in sales agreements with suppliers in which it also purchases inventory. As part of the five-step revenue model, the Company assesses whether instances of bulk sales made to suppliers of goods have commercial substance and should be recognized as revenue, or whether they should be assessed under ASC 845, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Nonmonetary Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which requires management judgment to determine if the transaction has commercial substance</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.752626672113803%;display:inline-flex;justify-content:flex-start;">iii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share-based payments</span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In calculating share-based compensation expense, key estimates are used such as, the rate of forfeiture of options granted, the expected life of the option, the volatility of the Company’s stock price, and the risk-free interest rate.</span></p><div style="margin-left:4.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.752626672113803%;display:inline-flex;justify-content:flex-start;">iv)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Warrant liability</span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In calculating the fair value of warrants issued, the Company includes key estimates such as the volatility of the Company’s stock price and the risk-free interest rate. The Company uses judgment to select methods used and in performing the fair value calculations at the initial measurement at issuance, as well as for subsequent measurement on a recurring basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:4.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.752626672113803%;display:inline-flex;justify-content:flex-start;">v)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Income taxes</span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The extent to which deferred tax assets can be recognized is based on an assessment of the probability of the Company generating future taxable income against which the deferred tax assets can be utilized. In addition, significant judgment is required in classifying transactions and assessing probable outcomes of tax positions taken, and in assessing the impact of any legal or economic limits or uncertainties in various tax jurisdictions.</span></p><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Provisions for taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these provisions at the end of the reporting period. It is possible, however, that at some future date, an additional liability could result from audits by taxing authorities. If the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made.</span></p><div style="margin-left:4.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.752626672113803%;display:inline-flex;justify-content:flex-start;">vi)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment of goodwill and indefinite lived intangible assets </span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company uses an income-based approach as necessary to assess the fair values of indefinite lived intangible assets, asset groups and reporting units for goodwill testing purposes. Under the income approach, fair value is based on the present value of estimated cash flows. An impaired asset is written down to its estimated fair value based on the most recent information available.</span></p><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fair value is determined as the amount that would be obtained from the sale of the asset in an arm’s length transaction between knowledgeable and willing parties. Determining the value in use requires the Company to estimate expected future cash flows associated with the assets and a suitable discount rate in order to calculate present value. A number of factors, including historical results, business plans, forecasts, and market data are used to determine the fair value of the reporting unit and intangible assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:2.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.840544616931553%;display:inline-flex;justify-content:flex-start;">vii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment of long-lived assets</span></div></div><p style="margin-left:9.067%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company evaluates the recoverability of long-lived assets, including property and equipment, ROU assets, and definite lived intangible assets, whether events or changes in circumstances indicate that the carrying value of the asset, or asset group, may not be recoverable. Judgment is required to evaluate whether one or more indicators of potential impairment exist. The assets are assessed for impairment based on the estimated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the carrying value of an asset</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:9.067%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">exceeds its estimated future undiscounted cash flows, an impairment loss is recorded for the excess of the asset’s carrying value over its fair value.</span></p><div style="margin-left:2.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.840544616931553%;display:inline-flex;justify-content:flex-start;">viii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Business combinations </span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Classification of an acquisition as a business combination or an asset acquisition depends on whether the asset acquired constitutes a business, which can be a complex judgment. The Company has determined that its acquisitions in Note 5 are business combinations under ASC, 805 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Business Combinations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In a business combination, substantially all identifiable assets, liabilities and contingent liabilities acquired are recorded at the date of acquisition at their respective fair values. One of the most significant areas of judgment and estimation relates to the determination of the fair value of these assets and liabilities, including the fair value of contingent consideration, if applicable. If any intangible assets are identified, depending on the type of intangible asset and the complexity of determining its fair value, the Company may utilize an independent external valuation expert to develop the fair value, using appropriate valuation techniques, which are generally based on a forecast of the total expected future net cash flows. These valuations are linked closely to the assumptions made by management regarding the future performance of the assets concerned and any changes in the discount rate applied.</span></p><div style="margin-left:2.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.840544616931553%;display:inline-flex;justify-content:flex-start;">ix)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Contingent consideration</span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Contingent consideration payable as the result of a business combination is recorded at the date of acquisition at fair value. The fair value of contingent consideration is subject to significant judgment and estimates, such as projected future revenue. Subsequent changes to the fair value of contingent consideration are measured at each reporting date, with changes recognized through profit or loss.</span></p><div style="margin-left:2.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.840544616931553%;display:inline-flex;justify-content:flex-start;">x)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Incremental borrowing rates</span></div></div><p style="margin-left:9.173%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease payments are discounted using the rate implicit in the lease if that rate is readily available. If that rate cannot be easily determined, the lessee is required to use its incremental borrowing rate. The incremental borrowing rate is the rate of interest that the Company estimates it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The Company calculates its incremental borrowing rate as the interest rate the Company would pay to borrow funds necessary to obtain an asset of similar value over similar terms taking into consideration the economic factors and the credit risk rating at the commencement date of the lease.</span></p><div style="margin-left:2.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.840544616931553%;display:inline-flex;justify-content:flex-start;">xi)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Control, joint control or level of influence</span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">When determining the appropriate basis of accounting for the Company’s interests in affiliates, the Company makes judgments about the degree of influence that it exerts directly or through an arrangement over the investees’ relevant activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:2.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.840544616931553%;display:inline-flex;justify-content:flex-start;">xii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employee Retention Tax Credit</span></div></div><p style="margin-left:9.067%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") provides for an Employee Retention Tax Credit ("ERC") which is a refundable tax credit for businesses that continued to pay employees while shut down due to the COVID-19 pandemic, or had significant declines in gross receipts from March 13, 2020 to December 31, 2021. Eligible employers were entitled to claim the ERC on an original or adjusted employment tax return for a period within those dates. The Company has elected to account for the ERC as a government grant. There is limited grant accounting guidance within U.S. GAAP that is applicable to for-profit entities. Therefore, the Company has elected to follow the grant accounting model in International Accounting Standard ("IAS") 20, Accounting for Government Grants and Disclosure of Government Assistance. Accordingly, the Company recognized government grants for which there is a reasonable assurance of compliance with grant conditions and receipt of credits and has therefore recognized a receivable for the total credit amount on the Consolidated Balance Sheet as of December 31, 2022 (refer to Note 4). The determination of the collectability of the ERC requires significant judgment, including assessment of the Company's eligibility based on the facts and circumstances. No formal determination has been made regarding the Company’s eligibility to receive ERC or if companies in the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:9.067%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">cannabis industry are generally eligible to receive ERC. There is a risk that a determination could be made that the Company, due to its operations or the nature of its business, is not eligible for the ERC distributions it has received.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:2.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.840544616931553%;display:inline-flex;justify-content:flex-start;">xiii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Variable Interest Entity</span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company consolidates legal entities in which it holds a controlling financial interest. Determining whether it has a controlling financial interest in VIE is subject to significant judgment and estimates. There is inherent uncertainty in evaluating who has the power to direct the activities of the VIE that most significantly impact the entity's economic performance. Our considerations include, but are not limited to, voting interests of the VIE, management, service and other agreements with the VIE, involvement in the VIE’s initial design and the existence of explicit or implicit financial guarantees. Management has applied significant judgment when evaluating the facts and circumstances of the VIE (Note 3).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:2.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.840544616931553%;display:inline-flex;justify-content:flex-start;">xiv)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Current Expected Credit Losses</span></div></div><p style="margin-left:9.08%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Management determines the current expected credit losses by evaluating individual receivable balances along with the consideration of other financial and current economic conditions. Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded as income when received. All receivables are expected to be collected within one year of the balance sheet date.</span></p>
CY2023Q4	tsndf	Trade Receivables Gross TradeReceivablesGross	28403000
CY2022Q4	tsndf	Trade Receivables Gross TradeReceivablesGross	14786000
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	408000
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	277000
CY2023Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	1154000
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	17936000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10917000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10556000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19048000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22443000
CY2022	us-gaap	Payments To Employees PaymentsToEmployees	14903000
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	12667000
CY2022Q4	tsndf	Factoring Interests FactoringInterests	14903000
CY2023	tsndf	Employee Retension Credits Transfer Fee As Percentage Of Claim EmployeeRetensionCreditsTransferFeeAsPercentageOfClaim	0.15
CY2023	tsndf	Percentage Of Repay Of Funds Received Plus Interest Accrued PercentageOfRepayOfFundsReceivedPlusInterestAccrued	0.10
CY2023	tsndf	Proceeds From Employee Retention Credit Financing Agreement ProceedsFromEmployeeRetentionCreditFinancingAgreement	13521000
CY2023Q4	tsndf	Trade Receivables Gross TradeReceivablesGross	28403000
CY2022Q4	tsndf	Trade Receivables Gross TradeReceivablesGross	14786000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10917000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10556000
CY2023Q4	tsndf	Trade Receivables Net TradeReceivablesNet	17486000
CY2022Q4	tsndf	Trade Receivables Net TradeReceivablesNet	4230000
CY2023Q4	tsndf	Trade Receivable Current TradeReceivableCurrent	13799000
CY2022Q4	tsndf	Trade Receivable Current TradeReceivableCurrent	4045000
CY2023Q4	tsndf	Trade Receivable3190 Days TradeReceivable3190Days	2837000
CY2022Q4	tsndf	Trade Receivable3190 Days TradeReceivable3190Days	614000
CY2023Q4	tsndf	Trade Receivable Over90 Days TradeReceivableOver90Days	11767000
CY2022Q4	tsndf	Trade Receivable Over90 Days TradeReceivableOver90Days	10127000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10917000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10556000
CY2023Q4	tsndf	Trade Receivables Net TradeReceivablesNet	17486000
CY2022Q4	tsndf	Trade Receivables Net TradeReceivablesNet	4230000
CY2023Q4	tsndf	Number Of Customers Agreed To Payment Plan Over Ninety Days NumberOfCustomersAgreedToPaymentPlanOverNinetyDays	1
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10556000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	335000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	14000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	324000
CY2023	tsndf	Expected Credit Losses ExpectedCreditLosses	668000
CY2022	tsndf	Expected Credit Losses ExpectedCreditLosses	10556000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	321000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	659000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10917000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10556000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	12535000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	750000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	7040000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1061000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	5184000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	2657000
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	750000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-645000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	6446000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	6446000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	7040000
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	378000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1181000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18821000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15280000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	28451000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	26406000
CY2023Q4	tsndf	Inventory Accessories Supplies And Consumables InventoryAccessoriesSuppliesAndConsumables	4033000
CY2022Q4	tsndf	Inventory Accessories Supplies And Consumables InventoryAccessoriesSuppliesAndConsumables	3468000
CY2023Q4	us-gaap	Inventory Net InventoryNet	51683000
CY2022Q4	us-gaap	Inventory Net InventoryNet	46335000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	985000
CY2022Q4	tsndf	Facility Held For Sale FacilityHeldForSale	67300
CY2023Q2	tsndf	Facility Sold FacilitySold	19700000
CY2023Q2	tsndf	Facility Sold FacilitySold	14285000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7001000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6809000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	229101000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	235496000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32886000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19684000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	196215000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	215812000
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	2079000
CY2023	tsndf	Property And Equipment Capitalized Borrowing Costs PropertyAndEquipmentCapitalizedBorrowingCosts	0
CY2022	tsndf	Property And Equipment Capitalized Borrowing Costs PropertyAndEquipmentCapitalizedBorrowingCosts	0
CY2023	us-gaap	Depreciation Depreciation	11517000
CY2022	us-gaap	Depreciation Depreciation	10043000
CY2021	us-gaap	Depreciation Depreciation	6137000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	190098000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	22360000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	167738000
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	48116000
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	48116000
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	238214000
CY2023Q4	tsndf	Intangible Assets Excluding Goodwill Accumulated Amortization IntangibleAssetsExcludingGoodwillAccumulatedAmortization	22360000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	215854000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	181522000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24575000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	156947000
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	82757000
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	82757000
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	264279000
CY2022Q4	tsndf	Intangible Assets Excluding Goodwill Accumulated Amortization IntangibleAssetsExcludingGoodwillAccumulatedAmortization	24575000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239704000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8865000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12581000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6652000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6795000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6714000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6714000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P27Y6M
CY2021Q4	us-gaap	Goodwill Goodwill	90326000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	170359000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	170357000
CY2022Q4	us-gaap	Goodwill Goodwill	90328000
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	21291000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4690000
CY2023Q4	us-gaap	Goodwill Goodwill	106929000
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	15518000
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	121527000
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2233000
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	35785000
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	19200000
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	1400000
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	51303000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	140727000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3633000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3633000
CY2022	tsndf	Impairment Of Cultivation And Processing Licenses ImpairmentOfCultivationAndProcessingLicenses	79462000
CY2022	tsndf	Impairment Of Retail Licenses ImpairmentOfRetailLicenses	42065000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4690000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	170357000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5007000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	11849000
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	9333000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	125888000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	39002000
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	137737000
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	48335000
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	61633000
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	145852000
CY2023Q4	us-gaap	Loans Payable LoansPayable	199370000
CY2022Q4	us-gaap	Loans Payable LoansPayable	194187000
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	23037000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	26840000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	21171000
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3491000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	644000
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.129
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	35000000
CY2022Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	5000000
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	35000000
CY2022Q4	tsndf	Percentage Of Prepayment Price PercentageOfPrepaymentPrice	1.0322
CY2023Q1	tsndf	Percentage Of Fee In The Amount Of Outstanding Principal Loan Balance PercentageOfFeeInTheAmountOfOutstandingPrincipalLoanBalance	0.01
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7896000
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	442000
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	28236000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	141946000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	7942000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	11082000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	44483000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1000000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	206453000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43440000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29451000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1244000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1857000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45384000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31545000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	46628000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	33402000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2112000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6673000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2030000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	521000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	407000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6713000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2437000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	7234000
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	6098000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	5028000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	3986000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y9M18D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1143
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1069
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0947
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0989
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	6264000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	5053000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16603000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3097000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	153000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	220000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6913000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7376000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2130000
CY2023Q4	tsndf	Operating And Finance Lease Liability Payments Due Next Twelve Months OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths	9506000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7398000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	132000
CY2023Q4	tsndf	Operating And Finance Lease Liability Payments Due Year Two OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	7530000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7158000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	134000
CY2023Q4	tsndf	Operating And Finance Lease Liability Payments Due Year Three OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	7292000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7014000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	136000
CY2023Q4	tsndf	Operating And Finance Lease Liability Payments Due Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	7150000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6852000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	80000
CY2023Q4	tsndf	Operating And Finance Lease Liability Payments Due Year Five OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive	6932000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	56207000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	1000
CY2023Q4	tsndf	Operating And Finance Lease Liability Payments Due After Year Five OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive	56208000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	92005000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2613000
CY2023Q4	tsndf	Operating And Finance Lease Liability Payments Due OperatingAndFinanceLeaseLiabilityPaymentsDue	94618000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	45377000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	176000
CY2023Q4	tsndf	Operating And Finance Lease Liability Undiscounted Excess Amount OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount	45553000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	46628000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2437000
CY2023Q4	tsndf	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	49065000
CY2023	tsndf	Conversion Option Issued In Private Placement ConversionOptionIssuedInPrivatePlacement	3600000
CY2023Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	6755000
CY2023Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1000
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of Common Shares are entitled to receive notice of, and to attend, all meetings of the shareholders of the Company and shall have one vote per each Common Share
CY2023	tsndf	Number Of Vote Per Each Common Share Held NumberOfVotePerEachCommonShareHeld	1
CY2023	tsndf	Proportionate Voting Share ProportionateVotingShare	0.001
CY2023Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	395000
CY2023	tsndf	Warrants And Rights Description WarrantsAndRightsDescription	Each equity unit is comprised of one Common Share and one-half of one Common Share purchase warrant. Each warrant entitles the holder to acquire one Common Share at a price of $1.95 per common share for a period of 24 months following the date of issuance.
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1643000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7707000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12162000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14942000
CY2017Q1	tsndf	Rolling Percentage RollingPercentage	0.15
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P1Y
CY2017Q1	tsndf	Percentage Of Issued And Outstanding Shares Reserved For Optioning PercentageOfIssuedAndOutstandingSharesReservedForOptioning	0.05
CY2017Q1	tsndf	Exercisable Percentage ExercisablePercentage	0.25
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17363348
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y11M15D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.49
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	112675000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3905000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.11
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1376496
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.97
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	6838347
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.46
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	198986
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.95
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12854519
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.85
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	27557000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7058840
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.69
CY2022	tsndf	Share Based Compensation Arrangement By Share Based Payment Award Replacement Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardReplacementOptionsGrantsInPeriod	4940364
CY2022	tsndf	Share Based Compensation Arrangements By Share Based Payment Award Replacement Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardReplacementOptionsGrantsInPeriodWeightedAverageExercisePrice	2.99
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	778245
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.62
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3397021
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.96
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	567211
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	7.14
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20111246
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M9D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.63
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	320000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2191627
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.69
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	416852
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.23
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3478453
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.45
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2129188
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.85
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16278380
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M26D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.35
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	658000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10944709
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y11M12D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.42
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	269000
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5333671
CY2023	tsndf	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P8Y4M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.21
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	389000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	558000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1355000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6667000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.7779
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.8016
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.7755
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.7789
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.7905
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.8151
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0285
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0426
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0163
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0351
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.009
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0172
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023	tsndf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate	0.2611
CY2022	tsndf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate	0.2611
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	122311
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	33733
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	174408
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	40665
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	63883
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	192171
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13294
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1176397
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	669478
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	283450
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	415640
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13050
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2387275
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1596814
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	127517
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1078584
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2374000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	5367000
CY2023	tsndf	Minority Interest Capital And Distributions Contributions MinorityInterestCapitalAndDistributionsContributions	-11622000
CY2022	tsndf	Minority Interest Capital And Distributions Contributions MinorityInterestCapitalAndDistributionsContributions	-7550000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8815000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4557000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1756000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2374000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	108000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	19000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-18615000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-35299000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1245000
CY2023	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Domestic IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesDomestic	-45490000
CY2022	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Domestic IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesDomestic	-337019000
CY2021	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Domestic IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesDomestic	15513000
CY2023	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Foreign IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesForeign	-13343000
CY2022	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Foreign IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesForeign	26834000
CY2021	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Foreign IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesForeign	29017000
CY2023	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58833000
CY2022	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-310185000
CY2021	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44530000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	30727000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21692000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21522000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	11279000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2718000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8600000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	62000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	106000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	42068000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24516000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	30122000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-13363000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-29297000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1353000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-5271000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-6002000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23453000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10783000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28877000
CY2023	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58833000
CY2022	tsndf	Income Loss From Continuing And Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingAndDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-310185000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-12355000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-65139000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	31960000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.543
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	28607000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.092
CY2023	tsndf	Income Tax Reconciliation Return To Provision True Up IncomeTaxReconciliationReturnToProvisionTrueUp	5342000
CY2023	tsndf	Effective Income Tax Rate Reconciliation Return To Provision True Up EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUp	-0.091
CY2022	tsndf	Income Tax Reconciliation Return To Provision True Up IncomeTaxReconciliationReturnToProvisionTrueUp	-7359000
CY2022	tsndf	Effective Income Tax Rate Reconciliation Return To Provision True Up EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueUp	0.024
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	985000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.017
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	35775000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.115
CY2023	tsndf	Income Tax Reconciliation Changes In Unrecognized Tax Benefits IncomeTaxReconciliationChangesInUnrecognizedTaxBenefits	3041000
CY2023	tsndf	Effective Income Tax Rate Reconciliation Changes In Unrecognized Tax Benefits EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefits	-0.052
CY2022	tsndf	Income Tax Reconciliation Changes In Unrecognized Tax Benefits IncomeTaxReconciliationChangesInUnrecognizedTaxBenefits	10662000
CY2022	tsndf	Effective Income Tax Rate Reconciliation Changes In Unrecognized Tax Benefits EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefits	-0.034
CY2023	tsndf	Income Tax Reconciliation Extinguishment Of Debt IncomeTaxReconciliationExtinguishmentOfDebt	173000
CY2023	tsndf	Effective Income Tax Rate Reconciliation Extinguishment Of Debt EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebt	-0.003
CY2022	tsndf	Income Tax Reconciliation Extinguishment Of Debt IncomeTaxReconciliationExtinguishmentOfDebt	-8239000
CY2022	tsndf	Effective Income Tax Rate Reconciliation Extinguishment Of Debt EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebt	0.027
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1619000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.028
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2554000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.008
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	155000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.003
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	19146000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.062
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2218000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.038
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-7067000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.023
CY2023	tsndf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrants EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrants	-68000
CY2023	tsndf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrant EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrant	0.001
CY2022	tsndf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrants EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrants	-12290000
CY2022	tsndf	Effective Income Tax Rate Reconciliation Revaluation Of Equity Or Warrant EffectiveIncomeTaxRateReconciliationRevaluationOfEquityOrWarrant	0.04
CY2023	tsndf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsideration	-136000
CY2023	tsndf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsiderationPercent	0.002
CY2022	tsndf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsideration	-223000
CY2022	tsndf	Effective Income Tax Rate Reconciliation Revaluation Of Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationRevaluationOfContingentConsiderationPercent	0.001
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-4632000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.079
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-4699000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.015
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23453000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.399
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10783000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.035
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18883000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9318000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	37337000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2872000
CY2023	tsndf	Unrecognized Tax Benefits Increases Decrease Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreaseResultingFromPriorPeriodTaxPositions	30250000
CY2022	tsndf	Unrecognized Tax Benefits Increases Decrease Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreaseResultingFromPriorPeriodTaxPositions	8655000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	1985000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	1962000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	84485000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18883000
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3100000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2170000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	84485000
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	77084000
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	13223000
CY2023Q4	tsndf	Unrecognized Tax Benefits That If Recognized Would Result In Adjustments To Other Accounts UnrecognizedTaxBenefitsThatIfRecognizedWouldResultInAdjustmentsToOtherAccounts	9429000
CY2022Q4	tsndf	Unrecognized Tax Benefits That If Recognized Would Result In Adjustments To Other Accounts UnrecognizedTaxBenefitsThatIfRecognizedWouldResultInAdjustmentsToOtherAccounts	6758000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	50440000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	42022000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	286000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	2837000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1039000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	4689000
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	5267000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3768000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	13402000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8700000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	70434000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	62016000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	62608000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	61274000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7826000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	742000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	24949000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	31442000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	52000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	25001000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	31442000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	17175000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	30700000
CY2023Q4	us-gaap	Fdic Indemnification Asset FDICIndemnificationAsset	91000
CY2023Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	4637000
CY2023	tsndf	Office And General Expense OfficeAndGeneralExpense	15748000
CY2022	tsndf	Office And General Expense OfficeAndGeneralExpense	26000000
CY2021	tsndf	Office And General Expense OfficeAndGeneralExpense	10091000
CY2023	us-gaap	Professional Fees ProfessionalFees	13119000
CY2022	us-gaap	Professional Fees ProfessionalFees	12942000
CY2021	us-gaap	Professional Fees ProfessionalFees	12041000
CY2023	tsndf	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	6441000
CY2022	tsndf	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	5302000
CY2021	tsndf	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	4523000
CY2023	tsndf	Facility And Maintenance Expense FacilityAndMaintenanceExpense	5180000
CY2022	tsndf	Facility And Maintenance Expense FacilityAndMaintenanceExpense	4050000
CY2021	tsndf	Facility And Maintenance Expense FacilityAndMaintenanceExpense	1396000
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	57336000
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	44814000
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	30256000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7707000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12162000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14942000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9658000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10318000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1858000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	115189000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	115588000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	75107000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	317328000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247829000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	194210000
CY2023	tsndf	Number Of Major Customers NumberOfMajorCustomers	0
CY2022	tsndf	Number Of Major Customers NumberOfMajorCustomers	0
CY2021	tsndf	Number Of Major Customers NumberOfMajorCustomers	0
CY2022	tsndf	Sales Returns SalesReturns	1040000
CY2023	tsndf	Loan Interest Accretion LoanInterestAccretion	35106000
CY2022	tsndf	Loan Interest Accretion LoanInterestAccretion	39059000
CY2021	tsndf	Loan Interest Accretion LoanInterestAccretion	24989000
CY2022	tsndf	Indemnification Asset Release IndemnificationAssetRelease	3973000
CY2021	tsndf	Indemnification Asset Release IndemnificationAssetRelease	4504000
CY2021	tsndf	Forgiveness Of Loan Principal And Interest ForgivenessOfLoanPrincipalAndInterest	1414000
CY2023	tsndf	Employee Retention Credits And Transfer Fee EmployeeRetentionCreditsAndTransferFee	2236000
CY2022	tsndf	Employee Retention Credits And Transfer Fee EmployeeRetentionCreditsAndTransferFee	-9440000
CY2022	tsndf	Debt Modification Fees DebtModificationFees	2507000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	301000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	206000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	230000
CY2023	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	37041000
CY2022	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	35893000
CY2021	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	27849000
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	563629000
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	579594000
CY2023	tsndf	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2022	tsndf	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	54986000
CY2022	tsndf	Derivative Addition On Acquisition DerivativeAdditionOnAcquisition	6756000
CY2022	tsndf	Fair Value Gain On Revaluation Of Warrants FairValueGainOnRevaluationOfWarrants	-59341000
CY2022	tsndf	Exercise Of Warrants ExerciseOfWarrants	-1690000
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	711000
CY2023	tsndf	Conversion Option Issued In Private Placement ConversionOptionIssuedInPrivatePlacement	3600000
CY2023	tsndf	Detachable Warrants Issued In Private Placement DetachableWarrantsIssuedInPrivatePlacement	2216000
CY2023	tsndf	Fair Value Gain On Revaluation Of Warrants And Conversion Option FairValueGainOnRevaluationOfWarrantsAndConversionOption	-1372000
CY2023	tsndf	Effects Of Movements In Foreign Exchange EffectsOfMovementsInForeignExchange	7000
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	5162000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1372000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	59341000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	58158000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-645000
CY2023	tsndf	Foreign Currency Fluctuating Percentage ForeignCurrencyFluctuatingPercentage	0.10

Files In Submission

Name	View Source	Status
0000950170-24-031450-index-headers.html	Edgar Link	pending
0000950170-24-031450-index.html	Edgar Link	pending
0000950170-24-031450.txt	Edgar Link	pending
0000950170-24-031450-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img128886138_0.jpg	Edgar Link	pending
img249584552_0.jpg	Edgar Link	pending
img249584552_1.jpg	Edgar Link	pending
img249584552_2.jpg	Edgar Link	pending
img249584552_3.jpg	Edgar Link	pending
img33789793_0.jpg	Edgar Link	pending
img33789793_1.jpg	Edgar Link	pending
img33789793_10.jpg	Edgar Link	pending
img33789793_100.jpg	Edgar Link	pending
img33789793_101.jpg	Edgar Link	pending
img33789793_102.jpg	Edgar Link	pending
img33789793_103.jpg	Edgar Link	pending
img33789793_104.jpg	Edgar Link	pending
img33789793_105.jpg	Edgar Link	pending
img33789793_106.jpg	Edgar Link	pending
img33789793_107.jpg	Edgar Link	pending
img33789793_108.jpg	Edgar Link	pending
img33789793_109.jpg	Edgar Link	pending
img33789793_11.jpg	Edgar Link	pending
img33789793_110.jpg	Edgar Link	pending
img33789793_111.jpg	Edgar Link	pending
img33789793_112.jpg	Edgar Link	pending
img33789793_113.jpg	Edgar Link	pending
img33789793_12.jpg	Edgar Link	pending
img33789793_13.jpg	Edgar Link	pending
img33789793_14.jpg	Edgar Link	pending
img33789793_15.jpg	Edgar Link	pending
img33789793_16.jpg	Edgar Link	pending
img33789793_17.jpg	Edgar Link	pending
img33789793_18.jpg	Edgar Link	pending
img33789793_19.jpg	Edgar Link	pending
img33789793_2.jpg	Edgar Link	pending
img33789793_20.jpg	Edgar Link	pending
img33789793_21.jpg	Edgar Link	pending
img33789793_22.jpg	Edgar Link	pending
img33789793_23.jpg	Edgar Link	pending
img33789793_24.jpg	Edgar Link	pending
img33789793_25.jpg	Edgar Link	pending
img33789793_26.jpg	Edgar Link	pending
img33789793_27.jpg	Edgar Link	pending
img33789793_28.jpg	Edgar Link	pending
img33789793_29.jpg	Edgar Link	pending
img33789793_3.jpg	Edgar Link	pending
img33789793_30.jpg	Edgar Link	pending
img33789793_31.jpg	Edgar Link	pending
img33789793_32.jpg	Edgar Link	pending
img33789793_33.jpg	Edgar Link	pending
img33789793_34.jpg	Edgar Link	pending
img33789793_35.jpg	Edgar Link	pending
img33789793_36.jpg	Edgar Link	pending
img33789793_37.jpg	Edgar Link	pending
img33789793_38.jpg	Edgar Link	pending
img33789793_39.jpg	Edgar Link	pending
img33789793_4.jpg	Edgar Link	pending
img33789793_40.jpg	Edgar Link	pending
img33789793_41.jpg	Edgar Link	pending
img33789793_42.jpg	Edgar Link	pending
img33789793_43.jpg	Edgar Link	pending
img33789793_44.jpg	Edgar Link	pending
img33789793_45.jpg	Edgar Link	pending
img33789793_46.jpg	Edgar Link	pending
img33789793_47.jpg	Edgar Link	pending
img33789793_48.jpg	Edgar Link	pending
img33789793_49.jpg	Edgar Link	pending
img33789793_5.jpg	Edgar Link	pending
img33789793_50.jpg	Edgar Link	pending
img33789793_51.jpg	Edgar Link	pending
img33789793_52.jpg	Edgar Link	pending
img33789793_53.jpg	Edgar Link	pending
img33789793_54.jpg	Edgar Link	pending
img33789793_55.jpg	Edgar Link	pending
img33789793_56.jpg	Edgar Link	pending
img33789793_57.jpg	Edgar Link	pending
img33789793_58.jpg	Edgar Link	pending
img33789793_59.jpg	Edgar Link	pending
img33789793_6.jpg	Edgar Link	pending
img33789793_60.jpg	Edgar Link	pending
img33789793_61.jpg	Edgar Link	pending
img33789793_62.jpg	Edgar Link	pending
img33789793_63.jpg	Edgar Link	pending
img33789793_64.jpg	Edgar Link	pending
img33789793_65.jpg	Edgar Link	pending
img33789793_66.jpg	Edgar Link	pending
img33789793_67.jpg	Edgar Link	pending
img33789793_68.jpg	Edgar Link	pending
img33789793_69.jpg	Edgar Link	pending
img33789793_7.jpg	Edgar Link	pending
img33789793_70.jpg	Edgar Link	pending
img33789793_71.jpg	Edgar Link	pending
img33789793_72.jpg	Edgar Link	pending
img33789793_73.jpg	Edgar Link	pending
img33789793_74.jpg	Edgar Link	pending
img33789793_75.jpg	Edgar Link	pending
img33789793_76.jpg	Edgar Link	pending
img33789793_77.jpg	Edgar Link	pending
img33789793_78.jpg	Edgar Link	pending
img33789793_79.jpg	Edgar Link	pending
img33789793_8.jpg	Edgar Link	pending
img33789793_80.jpg	Edgar Link	pending
img33789793_81.jpg	Edgar Link	pending
img33789793_82.jpg	Edgar Link	pending
img33789793_83.jpg	Edgar Link	pending
img33789793_84.jpg	Edgar Link	pending
img33789793_85.jpg	Edgar Link	pending
img33789793_86.jpg	Edgar Link	pending
img33789793_87.jpg	Edgar Link	pending
img33789793_88.jpg	Edgar Link	pending
img33789793_89.jpg	Edgar Link	pending
img33789793_9.jpg	Edgar Link	pending
img33789793_90.jpg	Edgar Link	pending
img33789793_91.jpg	Edgar Link	pending
img33789793_92.jpg	Edgar Link	pending
img33789793_93.jpg	Edgar Link	pending
img33789793_94.jpg	Edgar Link	pending
img33789793_95.jpg	Edgar Link	pending
img33789793_96.jpg	Edgar Link	pending
img33789793_97.jpg	Edgar Link	pending
img33789793_98.jpg	Edgar Link	pending
img33789793_99.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tsndf-20231231.htm	Edgar Link	pending
tsndf-20231231.xsd	Edgar Link	pending
tsndf-ex10_10.htm	Edgar Link	pending
tsndf-ex10_11.htm	Edgar Link	pending
tsndf-ex10_12.htm	Edgar Link	pending
tsndf-ex10_15.htm	Edgar Link	pending
tsndf-ex10_23.htm	Edgar Link	pending
tsndf-ex10_30.htm	Edgar Link	pending
tsndf-ex10_31.htm	Edgar Link	pending
tsndf-ex10_32.htm	Edgar Link	pending
tsndf-ex10_33.htm	Edgar Link	pending
tsndf-ex10_4.htm	Edgar Link	pending
tsndf-ex10_5.htm	Edgar Link	pending
tsndf-ex10_6.htm	Edgar Link	pending
tsndf-ex10_9.htm	Edgar Link	pending
tsndf-ex21_1.htm	Edgar Link	pending
tsndf-ex23_1.htm	Edgar Link	pending
tsndf-ex31_1.htm	Edgar Link	pending
tsndf-ex31_2.htm	Edgar Link	pending
tsndf-ex32_1.htm	Edgar Link	pending
tsndf-ex32_2.htm	Edgar Link	pending
tsndf-ex4_1.htm	Edgar Link	pending
tsndf-ex4_2.htm	Edgar Link	pending
tsndf-ex4_3.htm	Edgar Link	pending
tsndf-ex4_4.htm	Edgar Link	pending
tsndf-ex4_5.htm	Edgar Link	pending
tsndf-ex4_6.htm	Edgar Link	pending
tsndf-ex4_7.htm	Edgar Link	pending
tsndf-20231231_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TSNDF
TerrAscend Corp. Stock $tsndf

2024 Q1 Form 10-K Financial Statement

#000095017024031450 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSNDF TerrAscend Corp. Stock $tsndf

2024 Q1 Form 10-K Financial Statement

#000095017024031450 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSNDF
TerrAscend Corp. Stock $tsndf